We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...
A reescalating battle between pharmaceutical companies and pharmacy benefit managers is brewing in Washington, D.C., as ...
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
A CVS spokesperson said the Emory collaboration is the first time MinuteClinic has expanded into primary care services in ...
The Associated Press on MSN10d
CVS Health steers through rising insurance costs in a strong fourth quarterCVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The ...
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...
Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results